These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23301519)

  • 1. Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs.
    Nasrolahi Shirazi A; Tiwari R; Chhikara BS; Mandal D; Parang K
    Mol Pharm; 2013 Feb; 10(2):488-99. PubMed ID: 23301519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and application of hybrid cyclic-linear peptide-doxorubicin conjugates as a strategy to overcome doxorubicin resistance and toxicity.
    Mozaffari S; Salehi D; Mahdipoor P; Beuttler R; Tiwari R; Aliabadi HM; Parang K
    Eur J Med Chem; 2021 Dec; 226():113836. PubMed ID: 34537446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [(WR)
    Zoghebi K; Aliabadi HM; Tiwari RK; Parang K
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid Cyclic-Linear Cell-Penetrating Peptides Containing Alternative Positively Charged and Hydrophobic Residues as Molecular Transporters.
    Khayyatnejad Shoushtari S; Zoghebi K; Sajid MI; Tiwari RK; Parang K
    Mol Pharm; 2021 Oct; 18(10):3909-3919. PubMed ID: 34491768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, anticancer activities, and cellular uptake studies of lipophilic derivatives of doxorubicin succinate.
    Chhikara BS; Mandal D; Parang K
    J Med Chem; 2012 Feb; 55(4):1500-10. PubMed ID: 22276998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiproliferative activities of doxorubicin thiol conjugates and doxorubicin-SS-cyclic peptide.
    Darwish S; Sadeghiani N; Fong S; Mozaffari S; Hamidi P; Withana T; Yang S; Tiwari RK; Parang K
    Eur J Med Chem; 2019 Jan; 161():594-606. PubMed ID: 30396106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endosomal pH-activatable poly(ethylene oxide)-graft-doxorubicin prodrugs: synthesis, drug release, and biodistribution in tumor-bearing mice.
    Zhou L; Cheng R; Tao H; Ma S; Guo W; Meng F; Liu H; Liu Z; Zhong Z
    Biomacromolecules; 2011 May; 12(5):1460-7. PubMed ID: 21332185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A doxorubicin-CNGRC-peptide conjugate with prodrug properties.
    van Hensbergen Y; Broxterman HJ; Elderkamp YW; Lankelma J; Beers JC; Heijn M; Boven E; Hoekman K; Pinedo HM
    Biochem Pharmacol; 2002 Mar; 63(5):897-908. PubMed ID: 11911842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin-activated doxorubicin prodrugs containing a spacer reduce tumor growth and angiogenesis without systemic toxicity.
    Devy L; de Groot FM; Blacher S; Hajitou A; Beusker PH; Scheeren HW; Foidart JM; Noël A
    FASEB J; 2004 Mar; 18(3):565-7. PubMed ID: 14734647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.
    Chen Z; Zhang P; Cheetham AG; Moon JH; Moxley JW; Lin YA; Cui H
    J Control Release; 2014 Oct; 191():123-30. PubMed ID: 24892976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
    Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G
    Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic peptide-capped gold nanoparticles as drug delivery systems.
    Nasrolahi Shirazi A; Mandal D; Tiwari RK; Guo L; Lu W; Parang K
    Mol Pharm; 2013 Feb; 10(2):500-11. PubMed ID: 22998473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Evaluation of Homochiral Peptides Containing Arginine and Histidine as Molecular Transporters.
    El-Sayed NS; Miyake T; Shirazi AN; Park SE; Clark J; Buchholz S; Parang K; Tiwari R
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29966296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive intracellular accumulation of ID-6105, a novel anthracycline, in SK-OV-3 ovarian cancer cells.
    Shin DH; Choi KS; Park SA; Cho BS; Lee HS; Ryu JS; Kim TY; Lee CK; Song S; Chung YB
    Arch Pharm Res; 2008 Oct; 31(10):1355-61. PubMed ID: 18958428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease-Responsive Prodrug with Aggregation-Induced Emission Probe for Controlled Drug Delivery and Drug Release Tracking in Living Cells.
    Cheng Y; Huang F; Min X; Gao P; Zhang T; Li X; Liu B; Hong Y; Lou X; Xia F
    Anal Chem; 2016 Sep; 88(17):8913-9. PubMed ID: 27503607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
    Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
    Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
    Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
    Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors.
    Pan C; Cardarelli PM; Nieder MH; Pickford LB; Gangwar S; King DJ; Yarranton GT; Buckman D; Roscoe W; Zhou F; Salles A; Chen TH; Horgan K; Wang YH; Nguyen T; Bebbington CR
    Cancer Res; 2003 Sep; 63(17):5526-31. PubMed ID: 14500390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.
    Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE
    Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.